Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$7,817,450
+$26,171 QoQ
Shares Held
30,781
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#1,264
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. JNJ ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,817,450 | 30,781 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $7,791,279 | 31,874 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $6,752,363 | 32,628 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $6,288,518 | 33,915 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $5,343,805 | 34,984 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $6,112,032 | 36,855 | Shares | Defined | 2025-04-07 | |
| 2024-12-31 | $5,405,027 | 37,374 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $5,217,845 | 32,197 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $4,904,836 | 33,558 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $5,416,108 | 34,238 | Shares | Defined | 2024-04-08 | |
| 2023-12-31 | $5,387,780 | 34,374 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $5,267,931 | 33,823 | Shares | Defined | 2023-11-21 | |
| 2023-06-30 | $5,522,077 | 33,362 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $5,239,465 | 33,803 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $6,114,562 | 34,614 | Shares | Defined | 2023-01-06 | |
| 2022-09-30 | $5,702,733 | 34,909 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $6,139,360 | 34,586 | Shares | Defined | 2022-07-14 | |
| 2022-03-31 | $6,126,132 | 34,566 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,066,525 | 12,080 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $2,038,775 | 12,624 | Shares | Sole | 2021-10-22 | |
| 2021-03-31 | $2,261,784 | 13,762 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $2,170,269 | 13,790 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,927,576 | 19,664 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,756,488 | 19,601 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,596,505 | 19,801 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||